Accession Number: | 0000899243-19-017005 |
Date: | 2019-06-13 |
Issuer: | INFINITY PHARMACEUTICALS, INC. (INFI) |
Original Submission Date: |
SELBY NORMAN C
C/O INFINITY PHARMACEUTICALS, INC.
784 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.6 | 2019-06-13 | deemed execution date | A | 30,000 (a) | 2029-06-12 | common stock 30,000 | $1.60 | 0 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 1.6 | 2019-06-13 | deemed execution date | A | 10,000 (a) | 2029-06-12 | common stock 10,000 | $1.60 | 0 | direct |
ID | footnote |
---|---|
f1 | the option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer. |
f2 | the option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as lead independent director of the issuer's board of directors. |